C. R. Bard Inc. buy dimontalban
Start price
24.11.14
/
50%
€120.65
Target price
30.04.15
€180.40
Performance (%)
10.79%
End price
30.04.15
€133.27
Summary
This prediction ended on 30.04.15 with a price of €133.27. The prediction had a final performance of 10.79%. dimontalban has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
C. R. Bard Inc. | - | - | - | - |
iShares Core DAX® | -0.315% | -2.776% | 12.361% | 15.821% |
iShares Nasdaq 100 | 1.250% | 7.480% | 34.131% | 57.547% |
iShares Nikkei 225® | -1.284% | -2.199% | 5.146% | 3.302% |
iShares S&P 500 | 1.141% | 4.717% | 28.724% | 51.350% |
Comments by dimontalban for this prediction
In the thread C. R. Bard Inc. diskutieren
Monezin
Der Spezialist für medizinisches Equipment ist seit Jahren im Aufwind und einen soliden Trend sollte man nicht verpassen.
(Stop Loss Kurs erreicht)